Searched for
ZENITH DRUGS LISTING PREMIUM
Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...- Aastha Spintex IPO off to a steady start; issue subscribed 52% on Day 1. Check GMP & key detailsAastha Spintex IPO saw a steady start on Day 1, subscribed 52% by mid-session, with strong NII demand leading the response. The issue carri...
- CSM Technologies IPO fully subscribed on final day; GMP hints at 4% listing gain. Should you subscribe?CSM Technologies' IPO successfully crossed the finish line, fully subscribed on its final day, driven by strong retail investor interest. T...
- IPO-bound NSE set to be the change in exchange gameIndia's sole listed stock exchange, BSE, faces a significant shift as rival NSE files for its own listing. NSE, dominating market share, is...
- The hidden reason global capital is looking beyond India for future growthForeign investors are reallocating capital away from India towards markets like Taiwan and South Korea that offer stronger exposure to AI a...
- Manipur CM says drug trafficking routes have changed after 2023 crisis, largely diverting through MizoramManipur Chief Minister Yumnam Khemchand Singh revealed that drug trafficking routes have shifted significantly post-2023 crisis, largely di...
- ET Graphics: From budget to premium, gadget Prices RiseIndian consumers are facing a significant price hike on smartphones, laptops, and tablets, impacting both budget and premium devices. This ...
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
- Govt to amend NDPS Act to plug loopholes exploited by narco syndicates: Amit ShahUnion Home Minister Amit Shah announced plans to amend the NDPS Act to combat drug syndicates, emphasizing a strict approach against peddle...
- Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...
- CDSCO asks states, port offices to step up screening to curb imports of illegal drugsIndia's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...
- Advit Jewels IPO Day 3: Issue subscribed 213x on strong retail, NII demand; GMP hints at 40% listing gainsJaipur's Advit Jewels IPO is witnessing overwhelming investor interest, subscribed over 212 times by day three, with a significant 40% grey...
- Waterways Leisure Tourism IPO Day 3: Issue subscribed 69%, GMP signals flat debut. Should you apply?Waterways Leisure Tourism IPO: The IPO received a lukewarm response on its final day of bidding, with the issue subscribed only 69% overall...
- CSM Technologies IPO Day 2 update: Subscribed 32%, GMP at 4%. Should you subscribe?CSM Technologies' IPO is seeing a subdued response on its second day, with only 32% subscription. Retail investors show more interest, subs...
- Avience Biomedicals shares make blockbuster debut, list at 90% premium on NSE SMEAvience Biomedicals made a spectacular debut on the NSE SME platform, with its shares rocketing 90% on listing day. The Rs 30.24 crore IPO,...
- Diksha Polymers shares list at 2% premium to IPO price on BSE SME platformDiksha Polymers debuted on the BSE SME platform at a slight premium, opening at Rs 114.50 against its IPO price of Rs 112. The Rs 17.9-cror...
- CSM Technologies IPO opens: Check brokerage review, GMP and other detailsThe IPO will remain open until June 26. It is a book-built issue with a price band of Rs 147-155 per share. The issue comprises a fresh iss...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Central Drugs Laboratories find 46 drug samples not of standard quality for MayHealth officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...
- 16 fixed-dose combination drugs banned in India: Check full list hereFixed dose combination banned full list: India has banned 16 fixed-dose combination drugs, including certain antibiotics and antispasmodics...
Load More
